13th International Congress
THE "NEW FRONTIERS"
OF ARRHYTHMIAS 1998

January 24-31, 1998
Marilleva, Trento, Italy

RT-135

From genotype to phenotype. The case of the long QT syndrome

Peter J. Schwartz.
Cattedra di Cardiologia, Universita degli Studi di Pavia, Dipartimento di Cardiologia, Policlinico S. Matteo IRCCS, Pavia, Italy

Abstract

During the last few years several of the genes responsible for the long QT syndrome (LQTS) have been identified. These findings stimulated a widespread interest for the disease, involving molecular biologists and clinical cardiologists, for quite specific reasons. One is that all the LQTS genes identified so far encode for ionic channels involved in the control of ventricular repolarization. Another is that the expression of the mutated genes and the ensuing electrophysiologic studies have allowed to understand the mechanisms by which specific mutations are able to prolong action potential duration by selective alterations in the inactivation of the inward Na+ current or in the activation of two of the major repolarizing K+ currents.

The affected patients appear to have rather specific responses to interventions targeted toward the correction of the electrophysiologic consequences of their mutations. For instance, the patients with mutations on SCN5A, the cardiac sodium channel gene, respond with a significant shortening of the QT interval to mexiletine. Also, the ability to shorten the QT interval in response to heart rate increases, as they occur during exercise, varies according to the current affected by the various mutations. Finally, the circumstances involved in the onset of the syncopes and cardiac arrests of these patients vary in their frequency according to the genes involved. These ongoing observations will impact on the clinical management of the gene-carriers.

The long QT syndrome appears to be a unique model for the study of how tight can be the genotype-phenotype relation and represents a direct bridge between molecular biology and clinical cardiology.

Key Words

Arrhytmhogenesis  
long QT syndrome, controle of ventricular repolarization, gene disease, genotype, phenotype, OA

 

forward

CARDIOnet® - registered trade mark name
Copyright © 1996-1998 by CARDIOnet. All rights reserved.